5.87
Entrada Therapeutics Inc Borsa (TRDA) Ultime notizie
Why Entrada Therapeutics Inc. stock is trending among retail tradersTreasury Yields & Short-Term High Return Ideas - Trung tâm Dự báo KTTV quốc gia
Will Entrada Therapeutics Inc. stock maintain dividend yieldJuly 2025 Fed Impact & Low Risk High Reward Trade Ideas - Trung tâm Dự báo KTTV quốc gia
Multi factor analysis applied to Entrada Therapeutics Inc.Weekly Market Summary & Advanced Technical Analysis Signals - newser.com
How interest rate cuts could boost Entrada Therapeutics Inc. stockJuly 2025 Opening Moves & Weekly High Return Opportunities - Trung tâm Dự báo KTTV quốc gia
Is Entrada Therapeutics Inc. forming a bottoming baseJuly 2025 Setups & Trade Opportunity Analysis Reports - newser.com
Applying sector rotation models to Entrada Therapeutics Inc.July 2025 Momentum & AI Enhanced Execution Alerts - newser.com
Sector ETF performance correlation with Entrada Therapeutics Inc.Portfolio Growth Summary & AI Driven Stock Reports - newser.com
What’s the recovery path for long term holders of Entrada Therapeutics Inc.Market Risk Summary & Expert Verified Movement Alerts - newser.com
Best data tools to analyze Entrada Therapeutics Inc. stockPortfolio Update Report & AI Enhanced Execution Alerts - newser.com
Is it time to cut losses on Entrada Therapeutics Inc.July 2025 Pullbacks & Weekly High Conviction Trade Ideas - newser.com
Technical analysis overview for Entrada Therapeutics Inc. stockChart Signals & High Conviction Buy Zone Picks - newser.com
Signal strength of Entrada Therapeutics Inc. stock in tech scanners2025 Geopolitical Influence & Advanced Technical Analysis Signals - newser.com
Entrada Therapeutics, Inc.'s (NASDAQ:TRDA) Shares Bounce 32% But Its Business Still Trails The Industry - simplywall.st
Entrada Therapeutics (NASDAQ:TRDA) Earns Sell (D-) Rating from Weiss Ratings - MarketBeat
H.C. Wainwright maintains $20 target on Entrada Therapeutics stock - MSN
Entrada Therapeutics, Inc. (TRDA): Analyst Ratings Signal A 200% Upside Potential - DirectorsTalk Interviews
Analysts Set Entrada Therapeutics, Inc. (NASDAQ:TRDA) Target Price at $25.67 - Defense World
What’s next for Entrada Therapeutics Inc. stock priceStop Loss & Weekly Sector Rotation Insights - newser.com
What high frequency data says about Entrada Therapeutics Inc.Weekly Trend Report & Daily Chart Pattern Signals - newser.com
How to forecast Entrada Therapeutics Inc. trends using time series2025 Institutional Moves & Weekly Breakout Stock Alerts - newser.com
Can swing trading help recover from Entrada Therapeutics Inc. lossesTrade Exit Summary & Low Risk Profit Maximizing Plans - newser.com
Statistical indicators supporting Entrada Therapeutics Inc.’s strengthMarket Trend Summary & Growth Focused Entry Reports - newser.com
Why Entrada Therapeutics Inc. stock is in analyst buy zone2025 Earnings Impact & Low Volatility Stock Recommendations - newser.com
Entrada Therapeutics Inc Stock Analysis and ForecastMarket Rumors and News & Free Trading Psychology Coaching - earlytimes.in
What analysts say about Entrada Therapeutics Inc stockStochastic Oscillator Alerts & Exceptional Capital Trading - earlytimes.in
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):